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The ultimate objective of organ preservation is unre- 
stricted and immediate graft function after a transplant 
under optimal conditions in the most suitable recipient. 
This means that time and efficacy are the basic features 
of the search for the ideal preservation method. Theo- 
retically, freezing and continuous aerobic perfusion are 
the only means of obtaining truly long-term preser- 
vation (from a month to years). From a clinical point of 
view, however, the preferred method of preserving livers 
for brief periods before transplantation is simple cold 
storage (1). 
Until recently, cold storage of the graft in Collins’ 
solution provided acceptable graft function when pres- 
ervation time was 8 hr or less (2). Still, in the first report 
of the European Liver Transplant Registry (31, re- 
viewing 1,315 liver transplantations performed at 32 
different centers from 1968 to 1987, one of the principal 
causes of loss of the graft (and occasionally of death of 
the patient) appeared to be the so-called “primary 
nonfunction” of the liver. In most cases this was thought 
to be through an injury caused by inadequate preser- 
vation. To keep the period of cold storage to a minimum, 
close coordination of two full surgical teams -one for the 
donor and one for the recipient - was necessary, and the 
recipient operation had to be performed as an emergency 
procedure, often at  night. Furthermore, only a very 
narrow margin of safety existed in the storage time, in 
case of unforeseen delays or unanticipated, time- 
consuming difficulty in the recipient operation. 
To evaluate the possibility of liver transplantation on 
a (semi-) elective basis, Belzer (4) looked at the clinical 
needs for preservation times and concluded that 12 to 18 
hr was necessary for liver transplantation to be per- 
formed electively. 
Similar to kidney transplantation, (semi-) elective 
liver transplantation will yield substantial benefits: 
because simultaneous donor and recipient operations 
are not required, an unnecessary recipient laparotomy 
may be prevented if the donor organ appears unsuitable 
for transplantation. Furthermore, if laparotomy 
findings indicate that the recipient is unsuitable for 
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transplantation, extended preservation gives time for 
another patient to be prepared for transplantation. 
Because organs can be procured before final arrange- 
ments are made for the recipient, timing of the donor 
operation will be less critical; this will have particular 
merit when the donor’s condition is unstable. This 
implies an increase in efficiency of organ utilization and 
the number of donor organs. Extended preservation will 
also allow for more preparation time and well-rested 
support in anesthesia, nursing, operating room, blood 
bank and intensive care unit. The fact that the same 
surgeon can perform the donor operation and - after a 
rest period- the recipient operation, will allow recipient 
hepatectomy to be tailored for the donor organ. 
With the development of the University of Wisconsin 
(UW) solution (5) it is claimed that the goal of 
semielective liver transplantation has been achieved (6, 
7). Without a doubt, however, the search for improving 
available preservation methods will continue. Preser- 
vation times of more than 12 to 18 hr  will be necessary 
to enable assessment of the viability of the harvested 
organ, to apply immunomodulation of the recipient and 
to perform cross-matching based on analysis of tissue 
antigens. Although the importance of cross-matching in 
liver transplantation remains to be determined, repeat 
transplant candidates and highly sensitized patients 
may benefit from tissue typing. 
The main objective of this study was to summarize the 
history of organ preservation and to integrate the 
reported potential mechanisms of preservation damage 
to a generally applicable hypothesis on liver harvesting 
injury. This hypothesis was then used to discuss the 
rationale of the basic components of the UW solution 
and its current and future additives. 
HISTORY OF ORGAN PRESERVATION 
The first experiments in transplantation of the whole 
liver were hampered by the extreme sensitivity of this 
organ to anoxia (8,9). In 1956, Goodrich et al. (9) showed 
that normothermic complete anoxia for a period of 30 
min rendered the liver unsuitable for transplantation. 
The earliest device developed to protect the harvested 
liver was based on hypothermia: Starzl et al. (10) 
induced hypothermia by whole-body cooling of the donor 
to 30” C and then perfused the excised liver with cold 
Ringer’s lactate solution. In this way the hepatic core 
temperature fell to approximately 15” C. These organs 
then appeared to be able to sustain life in recipient dogs 
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if transplanted as orthotopic homografts within two 
hours. Although Sicular and Moore (1 1) demonstrated 
that canine liver cells in uztro stored at hypothermia 
remain functionally intact for about 4 hr after death, 
longer anoxic times in Starzl’s experiments resulted in a 
high rate of acute failure due to outflow block of the 
transplants, hemorrhagic diathesis and acute liver 
failure. Whereas the problem of outflow block was likely 
to be caused by spasm of the intrahepatic veins of the 
dog, hemorrhagic diathesis and acute liver failure, as 
would become evident later, were mainly the result of 
poor liver preservation. 
In the history of organ preservation, experiences in 
kidney and liver preservation frequently supplemented 
one another. Since the previously mentioned technique 
of infusion of cold electrolyte solution was the first 
effective method in liver preservation, it immediately 
became the standard for the quick cooling of the kidney 
(12). In 1963, Calne and coworkers (13) concluded their 
report on renal preservation by ice cooling as follows: 
“The cooling and rewarming periods can be reduced by 
perfusion techniques, which may be especially pertinent 
to the clinical application of cadaver transplants, since 
there is an inevitable delay in removing the kidney after 
death, and the relative large mass of the human kidney 
takes longer to cool by surface methods.” Obviously, this 
remark was even more appropriate for the large mass of 
the human liver. Consequently, most initial efforts to 
extend storage time were based on the concept of 
continuous hypothermic perfusion of the graft. In 1963, 
Marchioro and associates (14) reported a method of 
hypothermic cadaver perfusion with the use of an 
extracorporeal heart-lung machine. In 1965, Mikaeloff 
et al. (15) described an application of a method, reported 
in 1961 by Kestens and McDermott (16), in which 
hypothermic perfusion in situ was confined to the liver. 
Long-term recipient survival after homotransplantation 
of canine livers removed as long as 6 hr after death was 
achieved applying this technique. 
Other methods not based on continuous perfusion 
were also assessed. Brown et al. (17) and Moss, Reed and 
Riddell (18) evaluated preservation by means of freezing 
to -6“ C and -20” to -60” C, respectively. Organs 
preserved for 1 to 14 days in these experiments, 
however, were incapable of supporting life as orthotopic 
transplants. 
In 1967, a few years after Calne et al. (13) had stressed 
the importance of hypothermia in kidney preservation, 
Belzer, Ashby and Dunphy (19) demonstrated that 24-hr 
and 72-hr preservation of canine kidney was feasible by 
means of extracorporeal hypothermic pulsatile per- 
fusion. In the same year, Slapak, Wigmore and McLean 
(20) reported 24-hr preservation of the canine liver with 
a hypothermic, hyperbaric pulsatile perfusion tech- 
nique. The latter results, however, were achieved by 
transplanting the liver in the neck of the recipient 
animal; therefore it could not be established whether 
this method would be adequate to maintain the life of a 
hepatectomized animal. In fact, it soon became clear 
that compared with kidney transplantation, progress in 
preservation techniques of the liver was far less prev- 
alent. 
On March 1, 1963, the first human liver transplan- 
tation was performed by Starzl in Denver (21). Re- 
viewing 15 cases of clinical liver transplantation per- 
formed between 1963 and 1965 (22), Schalm et al. (23) 
noted that all homografts, except in one case, were 
revascularized within 3 to 3% hr of the death of the 
donor. Therefore they designed a preservation method 
of simple cooling and flushing of the liver in situ with a 
nonphysiological perfusion fluid, which was then re- 
placed by infusion of a plasma-based preservation fluid. 
The latter was intended to keep the vascular bed of the 
liver as intact as possible. This method provided a 
reliable preservation of about 3% hr of the liver 
homograft, as confirmed by successful heterotopic 
nonauxiliary transplantation in the dog. This tech- 
nique was then adapted and successfully used in 
the CambridgeKing’s College Hospital liver trans- 
plant program (24). Simultaneously, Collins, Bravo- 
Shugarman and Terasaki (2) reported successful canine 
kidney preservation with a similar technique of initial 
perfusion and 30-hr ice storage. Again, as with con- 
tinuous perfusion techniques, progress in kidney pres- 
ervation was far ahead of liver preservation. The 
DenverPittsburgh group subsequently started using 
the “Collins C2” formulation in liver transplantation 
(25). From that time on, two different pathways of liver 
preservation were continuously explored: the complex 
method of continuous or intermittent perfusion and the 
method of initial perfusion followed by simple hypo- 
thermic storage. 
Continuous Perfusion. In 1968, Brettschneider et al. 
(26) demonstrated that homografts could be effectively 
preserved for 8 hr  with a combination of hypothermia, 
hyperbaric oxygen and continuous perfusion with di- 
luted homologous blood through the portal vein and the 
hepatic artery. Another, relatively simple technique 
using continuous, hypothermic, asanguinous perfusion 
with cryoprecipitated plasma, which appeared to be 
consistently effective up to 10 hr (271, was not capable of 
successfully preserving porcine livers for 24 hr (28). 
Although the Cambridge group continued to use the 
previously described modified plasma protein solution 
clinically, the limitation of 3 to 4 hr  for hypothermic 
storage in many cases resulted in transplantation 
operations outside their own institution, with transfer 
of medical and nursing personnel and the recipient to 
the hospital where the donor had died. This caused 
many logistic problems and encouraged the Cambridge 
group to search for an  improvement of the compli- 
cated continuous perfusion apparatus with hyperbaric 
oxygen, which was available at that time. They de- 
veloped a single-passage, hypothermic, intermittent 
“squirt” perfusion technique that allowed preservation 
of porcine liver for up to 17 hr  (29). 
In the following 15 yr, relatively little progress was 
made, and although a few reports showed successful 
24-hr preservation (30, 31) and even incidental graft 
survival after 48-hr (32) preservation by perfusion 
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techniques, the diverse results merely reflected the 
problems in establishing a consistent technique. Among 
other factors, the type and length of preservation, the 
chemical characteristics of the perfusate, the actual 
technique of perfusion (intermittent/continuous, pulsa- 
tilehonpulsatile) and the individual response of the liver 
to hypothermic preservation were responsible for vari- 
ations in the results. Moreover, continuous perfusion 
techniques have the disadvantages of being expensive, 
technically complex, bulky and not easily portable. 
Therefore these methods found little favor in clinical 
practice. 
Just before the breakthrough in liver preservation 
discussed below, continuous hypothermic perfusion 
with a modified isotonic citrate solution was described as 
providing reliable 48-hr preservation of rat liver (33). In 
addition, promising results were recently reported by 
Nakajima et al. (341, who used an artificial blood 
substitute based on a stabilized hemoglobin solution. 
Successful 48-hr preservation of the canine liver was 
achieved by continuous hypothermic perfusion, with 
viability assessed by orthotopic transplantation. 
Simple H y p o t h e m i c  Storage. In 1971, Abouna et al. 
(35) and Spilg et al. (36) reported successful liver 
transplantation after simple cold storage of the graft for 
6 to 8 hr, using balanced salt solutions to which dextrose 
was added. After the initial perfusion in the experiments 
of Spilg et al., livers were stored in a second solution that 
was mainly composed of fresh frozen plasma. The 
solution Abouna used for graft storage was almost the 
same as the flush solution. Except in the report of Mieny 
and Myburgh (37), who successfully transplanted four 
baboon livers after 20-hr preservation with a chilled 
dextran-electrolyte-sorbitol solution, until 1979 reliable 
preservation time remained well under 12 hr: in 1977, 
Benichou et al. (25) reported a comparison between 
Ringer’s lactate, Schalm’s solution as modified by Wall 
et al. (24) and Collins’ solution (2). Surprisingly, all 
three fluids appeared effective in preserving liver grafts 
for 9 hr; this was much longer than one would be led to 
expect by the previous reports on simple cold storage, 
particularly with regard to Ringer’s lactate. Benichou et 
al. concluded therefore that hypothermia is the most 
important determinant for success in short-term pres- 
ervation, no matter the solution. However, the extra 
value of the special composition of a solution became 
clear in 18-hrs cold storage: Ringer’s lactate yielded 
significantly worse results than did the other two 
solutions. In the same report these authors described 
clinical preservation with a modified Collins’ solution in 
seven patients, with preservation times varying from 6Y2 
to  10 hr. Subsequently, most centers started to use the 
modified Collins’ solution or its more recent derivative, 
Euro-Collins, for human liver preservation (38) and 
continued to do so until 1988. In that year UW solution 
dramatically improved liver preservation by simple cold 
storage; this will be described below. 
The only report of successful preservation by simple 
cold storage, preceding the UW solution era, was in a 
model with auxiliary liver transplantation (39). Toledo- 
Pereyra and associates (39) showed that it is possible to  
store canine livers hypothermically for 24 hr after 
flushing with crystalloid or colloid hyperosmolar solu- 
tions. They used Sacks’ solution, which is comparable to 
Collins’ solution (40), as crystalloid hyperosmolar so- 
lution, and as colloid hyperosmolar solution they used 
the modified silica gel fraction of plasma (developed by 
the same group [30]), which is comparable to the 
Cambridge modification of Schalm’s solution (24). These 
favorable results with auxiliary transplantation are even 
more conspicuous when the results of a similar exper- 
iment conducted by Tamaki, Kamada and Pegg in 1985 
(41) are taken into account: they were able to preserve 
liver grafts for a cold ischemic period of only 6 hr, but 
completely failed to do so for 18 hr, using Collins’ 
solution and the modified Schalm’s plasma protein 
fraction solution in orthotopic transplantation in the 
rat. 
Recently, Belzer and Southard at  the University of 
Wisconsin (Madison, WI), succeeded in producing a 
remarkably effective solution for liver preservation, the 
so-called UW-solution (5). It was conceived on the basis 
of a thorough understanding of organ damage and 
protection mechanisms. This knowledge was gathered 
by extensive analysis of the basic principles of anaerobic 
hypothermic ischemia and organ-specific metabolism. 
Therefore, before the development of UW solution is 
explained, various basic aspects of harvesting injury to  
the liver are elucidated in the next section. 
MECHANISMS OF HARVEST INJURY 
Literature provides numerous reports that merely 
focus on one or two of the determinants of the 
multifactorial pathogenesis of harvesting injury. This 
may lead to seemingly inconsistent results. Apart from 
the fact that various experimental designs are used in 
different animal models, the most prominent determi- 
nants of these contradictions are anoxic vs. reperfusion 
damage, parenchymal vs. nonparenchymal damage and 
warm and cold ischemia. 
After removal of an organ from the circulation of the 
donor, the most logical way of keeping the harvested 
organ viable is perfusion by oxygenated whole blood with 
a heart-lung machine. The results and dilemmas of this 
approach are already described above. Any practical 
preservation method should consist of the (temporary) 
withdrawal of blood flow from the organ, which neces- 
sitates a period of ischemia after organ procurement and 
a moment of reperfusion during the recipient procedure. 
Injury may be induced by ischemia (literally, absence of 
b1ood)per se because it necessitates flushing of the donor 
organ, which in its turn may result in interstitial and 
cellular swelling when inappropriate fluids are used. 
This is, however, usually not the type of organ damage 
denoted by the expression “ischemic damage.” In fact, it 
is a misnomer because hypoxia or anoxia is what is 
generally referred to, and “anoxic damage” would be a 
better term (42). Anoxic and reperfusion damage are the 
two principal mechanisms of harvest injury. Accord- 
ingly, for these mechanisms, differences between paren- 
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chymal and nonparenchymal damage and between 
warm and cold ischemia are discussed separately. 
Anoxic Damage. In aerobic cells the energy necessary 
to maintain cell integrity is supplied by the mito- 
chondrial cytochrome system through complete (tet- 
ravalent) reduction of oxygen to water. This involves 
the generation of ATP, by which means the energy is 
stored for later consumption (oxidative phosphoryla- 
tion). These terminal reactions in aerobic glycolysis 
need a continuous supply of oxygen. As cells become 
anoxic, oxidative phosphorylation ceases and - without 
precautions - the stored ATP is consumed very rapidly. 
Since practically all energy-dependent functions use 
ATP, this molecule plays a central role in the viability of 
cells. Lack of ATP leads to cell injury by impairment of 
energy-dependent intracellular homeostatic functions. 
Subsequent to ATP depletion, diverse sequelae cul- 
minate in lethal cell injury. Therefore ATP can be 
considered the initial common pathway of cell death in 
organ preservation. 
The pathway from ATP deficit to irreversible cell 
damage is obscure. However, some microscopic aspects 
of the cell surface (i.e., loss of microvilli and “blebbing”) 
seem to be fairly constant. Cell surface blebbing is 
described by Lemasters et al. (43) in a sequence of events 
in which the sudden progression from reversible to 
irreversible injury is associated with and considered to 
be caused by rupture of a terminal cell surface bleb. 
Blebbing is thought to be a direct result of disruption of 
the cytoskeleton. Since cellular microfilaments and 
microtubules, of which this cytoskeleton is composed, 
are in an energy-requiring, dynamic state of continuous 
formation and disassembly, ATP deficiency may be 
directly related to this phenomenon. Other mechanisms, 
however, are suggested also and will be discussed below. 
ATP can be saved by cooling the organ, which reduces 
the tissue’s metabolic demands for nutrients and 
oxygen. Therefore, hypothermia plays an essential role 
in the preservation of the anoxic cell. Alone, it is effective 
in prolonging the time during which anoxic tissue will 
remain viable (6). However, this advantage is gained at  
a price because the intracellular homeostatic functions 
are decelerated equally. All measures that must be taken 
to prevent damage from loss of cellular homeostatic 
capacity constitute the toll for hypothermia-induced 
reduction of the metabolic rate. Although theoretically 
the cell will ultimately be confronted with the same 
dangers as in warm ischemia, viability will be jeopar- 
dized earlier through changes induced by the loss of 
homeostatic capacity. Obviously, in the process of 
extending the cold-ischemic period, when the most 
important obstacle is overcome, progress will go just as 
far as the second, most important metabolic disturbance 
allows. In addition, every measure in itself has the 
potential of introducing new threats for the already 
compromised cells. 
Disturbance of the electrolyte balance is a major 
consequence of slowing the metabolism by hypothermia. 
Normally, the cells are bathed in an interstitial fluid 
high in sodium (Na + 1 and calcium (Ca2 + and low in 
potassium (K’ ), compared with the intracellular elec- 
trolyte concentrations (44). The intracellular concentra- 
tions of Na’ and K’ are maintained by an energy- 
dependent cation transport system in the cell membrane 
(45, 46). This enzyme system, Na+/K+-activated (AT- 
Pase) uses ATP to make Na’ impermeable outside the 
cell, counteracting the colloidal osmotic pressure derived 
from the intracellular proteins and other impermeable 
anions, and causes K+  to accumulate in the cell. 
Hypothermic preservation suppresses the activity of this 
Na + pump and decreases the membrane potential of the 
plasma membrane. Consequently, chloride (C1- ) enters 
the cell down a concentration gradient with a cation and 
water to cause cell edema (4). Because this process leads 
to progressive cellular destruction, retention of intra- 
cellular electrolytes is a primary requirement for suc- 
cessful organ preservation (47). 
The extracellular fluid is very rich in calcium (Ca2 ’ 1 
( lop3  M) compared with the intracellular Ca“ concen- 
tration ( M). In addition, the electrical potential 
across the plasma membrane tends to drive Ca“ + in the 
cells. Such a large electrochemical gradient is main- 
tained by the relative impermeability of the plasma 
membrane to Ca2- (48) and by active extrusion from the 
cell. 
Some considerations must be given at this point to the 
matter of the Ca2 + being a biological messenger. It has 
been more than a century since Ringer (49) noticed that 
isolated hearts did not beat in the absence of Ca2+. 
Although 99% of Ca2+ in the human body is present in 
the bones, it is nowadays clear that Ca2 plays a unique 
role in transmitting “signals” generated at the plasma 
membrane to a large number of target functions inside 
the cell (50). The intracellular Ca2 + modulated (enzyme) 
functions are adjusted by variations in Ca2 + activity in 
a narrow range, around p,mol/L. Therefore the mes- 
senger function requires that intracellular Ca2 + be 
maintained at a very low activity level to switch targets 
on and off. This is achieved in two ways: by complexing 
the Ca“+ that has entered the cell down the concen- 
tration and electrical gradient from the extracellular 
space and by transporting the Ca”’ reversibly across 
various membrane systems. Three membrane systems 
have been shown able to transport Ca2 + : the plasma 
membrane, the sarcoplasmatic and endoplasmatic re- 
ticulum and the mitochondrion. The intracellular Ca2 + - 
transporting membranous network probably predomi- 
nates over the plasma membrane in the rapid regulation 
of Ca2+ (50). 
The type of interaction between Ca2+ and the target 
molecule is, in most cases, not known. However, in the 
last few years a small-molecular-weight protein has been 
discovered to be an important factor mediating the 
transmission of the Ca2’ signal and its interaction with 
the target function (Table 1). This ubiquitous molecule, 
discovered by Cheung in 1967 (511, is termed “calmod- 
ulin.” It is inactive in itself, the active form being the 
Ca2 * -calmodulin complex, which binds reversibly to the 
target enzyme (50). 
Besides Ca2 t ,  another important biological mes- 
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senger has been identified: cyclic AMP (CAMP) (52). 
However, complications are added to the issue by the 
fact that the Ca" + -calmodulin complex activates two key 
enzymes with opposite functions in the metabolism of 
CAMP: adenylate cyclase (generation) and phosphodi- 
esterase (breakdown). 
Obviously, at the current stage it is impossible to 
present a reasonable generalized model of the exact role 
of Ca" + in cell death. However, because a large number 
of Ca"' membrane transport systems appear to have 
been invoked by evolutionary pressure, the importance 
of the messenger function of Ca2+ and the resulting 
necessity of regulating its activity inside cells with 
utmost efficiency and precision cannot be overlooked. 
Several ways exist by which warm and cold ischemia 
may lead to altered Ca" + homeostasis (53). Depletion of 
ATP stores inhibits the ATP-dependent pumps to ex- 
trude Ca"' from the cell and the energy-dependent 
shuttles of the organelle membranes. In addition, the 
decrease in pH will induce a release of normally 
complexed Ca2+ as free ions. Other ions may also be 
related to pathological fluxes of Ca2 ' -for instance, the 
Na +/K+ homeostasis, which is also seriously changed 
during ischemia, as described above. Cold ischemia in 
particular leads to decreased membrane fluidity, which 
in itself-or in combination with cellular swelling- may 
be related to abnormal Ca" + movement. Considerable 
evidence shows that cytosolic changes in Ca" + levels are 
evoked both by release from intracellular depots and by 
pathologic influx through the plasma membrane 
(54-56). Unless the extrusion of Ca"' from the cell is 
also influenced, only a transient increase in cytosolic 
Ca" + level would be expected after the release of Ca2 + 
from intracellular stores (57). 
Many studies have associated these elevated Ca2+ 
levels with biochemical changes and histological damage 
and cell death (53, 57, 58). In an interesting report, 
Schanne and associates (48) described how accumu- 
lating intracellular Ca"+ can induce cell death. They 
found that rat hepatocytes can be destroyed with the 
cytotoxic compound A23 187, whose only known specific 
biological activity is to create Ca2+ channels that 
overcome the permeability barrier of the plasma mem- 
brane. Furthermore, these investigators showed an 
absolute requirement for extracellular Ca" + in the 
killing of primary cultures of adult rat hepatocytes by 
nine other toxins. Because all the toxins they used are 
capable of interacting with cell membranes, an interpre- 
tation of this Ca" + dependence in cell death is that each 
agent requires extracellular Ca" + to produce membrane 
injury. Besides the fact that it seems very unlikely that 
all 10 toxins would be dependent on Ca" + , some of these 
agents have been shown capable of producing membrane 
disruption without the presence of Ca2 + . Therefore the 
most plausible explanation is that in each case, the toxin 
causes disruption of the permeability barrier function of 
the plasma membrane, allowing a lethal influx of Ca2 + 
down the steep electrochemical gradient between the 
outside and the inside of the cell. 
The exact way in which Ca" ' brings about cell death 
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Myosin light chain kinase 
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Microtubules disassembly 
is open to speculation. Ca2+ plays a critical role in the 
maintenance of the structure and function of platelet 
cytoskeleton: Bellomo and Orrenius (57) described 
menadione-induced oxidative stress on the platelet 
cytoskeleton to be Ca2+-dependent, either as a direct 
consequence of the increase of cytosolic Ca"' or me- 
diated through the activation of Ca" ' -dependent pro- 
teases. Blebbing as described above is therefore fre- 
quently associated with elevated Ca" + levels. However, 
Lemasters et al. (43) demonstrated blebbing of hepato- 
cytes in a model of chemical hypoxia without a rise in 
cytosolic Ca". This controversy may be due to the 
variety of mechanisms by which Ca" ' homeostasis is 
thought to be altered and to dissimilar relative impor- 
tance of these mechanisms in both cold and warm 
ischemia. On the other hand, it means that disturbances 
in the cytoskeleton and cell surface blebbing are not 
exclusively caused by Ca" + increase. 
Another possible mechanism of Ca" +-induced damage 
is activation of phospholipases (59). These enzymes 
remove fatty acids from membranes without the aid of 
oxygen. Since catabolism of fatty acids does require 
oxygen, fatty acids accumulate and the bilayer mem- 
brane configuration is disturbed (53). 
In addition, Ca2+ is a regulator of a number of 
proteases, of which the conversion of xanthine dehydro- 
genase (XD) to xanthine oxidase (XO) is thought to play 
a significant role in the origin of preservation damage 
(60). However, the deleterious effects of phospholipase 
and protease activation may be of more importance 
during reperfusion, which will be discussed below. 
Although the rate of metabolism is greatly reduced 
under cold-storage conditions, the cell still needs some 
energy. In the absence of oxygen, the cell is able to draw 
this energy from anaerobic glycolysis and glycogenolysis, 
which entail increased production of lactic acid and 
hydrogen ions. The resulting tissue acidosis can damage 
cells and induce lysosomal instability, activate lysosomal 
enzymes and alter mitochondria1 properties (5). On the 
other hand, mild extracellular acidosis has been shown 
to be protective against the onset of irreversible injury to 
hepatocytes during ischemic stress (61, 62). In hepato- 
cytes depleted of ATP by chemical hypoxia, Gores et al. 
(63) showed this protective effect of cellular acidosis to 
be mediated by intracellular pH. In that report, because 
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FIG. 1. Harvest injury from cold ischemia as  measured by several biochemical and structural studies. The total amount of damage ( + 1 is split 
into its components: anoxic damage to hepatocytes (h), anoxic damage to endothelial cells (e) and reperfusion damage (r). This graph shows that 
endothelial damage always exceeds hepatocyte damage. In addition, we show that reperfusion damage will initidly be the most important factor 
fdetection threshold). In extended ischemic periods, however, measures to prevent reperfusion damage will no longer be able to inhibit the total 
amount of injury to progress beyond the viability threshold. 




Unsaturated and thiol-containing Protein denaturation and cross-linking, enzyme inhibition, organelle and cell permeability 
Nucleic acid bases Cell cycle changes, mutations 
Carbohydrates Cell surface receptor changes 
Unsaturated lipids Cholesterol and fatty acid oxidation, lipid cross-linking, organelle and cell permeability changes 
Cofactors Decreased nicotinamide and flavin-containing cofactor availability and activity, ascorbate oxi- 
Neurotransmitters Decreased neurotransmitter availability and activity, including serotonin and epinephrine 
Antioxidants Decreased availability, including a-tocopherol and p-carotene 
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DNA Strand scission, base modification 
Hyaluronic acid Change in synovial fluid viscosity 
amino acids changes 
dation, porphyrin oxidation 
anaerobic glycolysis is also inhibited in chemical hy- 
poxia, the most important source of intracellular aci- 
dosis was considered hydrolysis of ATP. The mechanism 
of this protection by intracellular acidosis is unknown, 
but it is hypothesized that acidic pH suppresses autolytic 
degradative processes by proteases and phospholipases 
activated by ATP depletion as described above. 
Most of the above-mentioned experiments focus on 
the hepatocyte. It is, however, well established that in 
ischemia endothelial lesions appear earlier than do 
parenchymal lesions. This concerns both warm (64) and 
cold (64-66) ischemic damage. Although the paren- 
chymal cells may be viable after a certain period of 
preservation, graft survival will not be achieved when 
endothelial cells are lethally injured. This may explain 
the dissociation between functional tests of preserved 
hepatocytes and graft survival. 
Focusing on cold ischemic damage only, it appears 
that microcirculatory damage will always be the critical 
factor. The correlation between the duration and the 
amount of anoxic damage (i.e., injury without reper- 
fusion) to parenchymal and nonparenchymal cells and of 
reperfusion injury, as measured by several biochemical 
(67, 68) and structural (64-66) studies, is depicted in 
Figure 1. 
Although Holloway et al. (65) demonstrated that UW 
solution and isotonic citrate solution provide significant 
protection against injury to the hepatic microcirculation 
by cold preservation, they could not identify the mech- 
anisms by which this protective effect was induced. In 
addition, evidence has accumulated showing that micro- 
circulation suffers mostly at and after reperfusion. 
Anoxic damage through basis of warm ischemia may 
be partially caused by ATP depletion in itself and by the 
ensuing disturbances in the cytoskeleton. Because Ca“ + 
accumulation needs some time and because low temper- 
atures render organelles especially susceptible to cyto- 
solic Ca2 + changes (69), elevated Ca”’ levels may be the 
most important pathway through which cold ischemic 
damage is induced, the decisive factor being the sinu- 
soidal lining cells. This damage, however, will probably 
not be manifest until the moment of reperfusion. 
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Cytochrome oxidase complex 
Superoxide dismutases 
FIG. 2. The univalent pathway for reduction of molecular oxygen. The enzymatic defense mechanisms to bypass and prevent the accumulation 
of reactive intermediates are also shown. 
Reperfusion Damage. It is well established that 
many organs suffer from considerable damage induced 
immediately after a period of either warm or cold 
ischemia at reperfusion (70). The ischemic intestine 
(71, 72) and lung (73, 74) have been shown to be 
particularly susceptible to this reperfusion injury, and 
involvement of oxygen-derived free radicals in the 
pathophysiology of the cell damage has been suggested. 
Postischemic injury as a consequence of generation of 
cytotoxic metabolites of oxygen may also be significant 
in other organs, including the kidney (75-771, heart 
(78-801, pancreas (81), liver (82) and skin (83). Because 
oxygen-derived free radicals appear to play such an 
important role in the mechanism of reperfusion injury, 
the background of oxygen-derived free radicals will be 
reviewed first. 
Oxygen-derived Free W i c a l s .  A normal chemical 
bond consists of a pair of electrons sharing a single 
molecular orbit. A free radical is any atom, group of 
atoms or molecule that has one unpaired electron 
occupying an outer orbit (84). This should not be 
confused with ions whose positive (Na’) or negative 
charge (Cl-) depends on the relationship of the number 
of electrons to the number of protons. Free radicals may 
be considered to contain an open bond or half a bond, 
rendering them chemically highly reactive and, 
therefore, transient. In chemical formulas the odd 
electron is symbolized by a dot. Free radicals can occur 
in both organic (e.g., quinones) and inorganic molecules 
(e.g., 0 , ~  ) and are critical in the normal operation of a 
wide spectrum of biological processes (85). 
Biological reactions concerning free radicals can be 
classified as initiation reactions, propagation reactions 
and termination reactions (84). The formation of a free 
radical, for instance, by radiolysis, photolysis or during 
oxidation-reduction reactions, is termed initiation. Free 
radicals can then proceed further by free radical inter- 
mediates, termed propagation reactions, which may be 
thousands of events long. If two radicals react, both 
radicals are eliminated from the propagating pool: this is 
termination. Virtually all cell components are capable of 
reacting with free radicals. Chemical modification of 
these molecules leads to metabolic and structural mod- 
ifications of cells that can ultimately cause cell death. 
Notable cellular components at risk from free radical 
damage include proteins, membrane lipids, nucleic acids 
and DNA (Table 2). 
Most cells use the oxidation potential of 0, to 
enormous advantage in the cytochrome system, where 
reduction to water is used to generate ATP (86). 
However, the cytochrome system may have evolved 
mainly as a means for the detoxification of oxygen, a 
mechanism that was only secondarily exploited for its 
energy-producing capacity through selective pressures 
for more efficient metabolism of scarce organic carbon 
substrates. 
Under normal conditions, most 0, in biological 
systems undergoes tetravalent reduction by efficient 
intracellular systems such as the cytochrome complex 
(87). However, 1% to 2% of 0, “leaks” from this 
pathway to undergo univalent reduction, as illustrated 
in Figure 2 (88). As can be seen in this figure, the 
univalent pathway results in the formation of 0,. 
(superoxide anion or superoxide radical), H,O, (hy- 
drogen peroxide) and OH- (hydroxyl radical) as the 
intermediates. These intermediates are too reactive to 
be tolerated in living tissue, and their removal and 
control has been the challenge of all aerobic organisms 
since the first appearance of 0, in the atmosphere. 
The protective and controlling mechanisms can be 
divided into enzymatic, hydrophobic, hydrophilic and 
structural groups, as shown in Table 3 (84). In Figure 2, 
the enzymatic bypass mechanisms are depicted in 
relation to the univalent pathway. 
Oxygen-derived Free Radicals and Hepatic Reper- 
fusion 1q~h-y .  Various sources of oxygen-derived free 
radicals are suggested. According to McCord (601, the 
major source of the oxygen-derived free radicals is XO 
(89). This enzyme-of which rich sources are present in 
the intestine, lung and liver - is synthesized in the form 
of XD. This form accounts for about 90% of the total 
activity in healthy tissue. XD does not produce oxygen- 
derived free radicals, but can reduce NAD + to form uric 
acid from xanthine: 
Xanthine + H,O + NAD ‘ - (XD) + Uric acid + NADH + H + 
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TABLE 3. Classification of protective controlling mechanisms 
of oxygen-derived free radicals 
Main group Example 
Enzymatic 
Hydrophobic 
Superoxide disrnutase, catalase and perox 
idase (cytochrorne oxidase) 
a-Tocopherol (vitamin E) and p-carotenes 
in cellular membranes, glutathione per- 
oxidase 
tathione, ceruloplasmin and transferrin 
in plasma 
Structural Cholesterol in biomernbranes, localization 
of certain reactions to peroxisomes and 
mitochondria 
Hydrophilic Ascorbic acid and cysteine, reduced glu- 
XO can use 0, instead of NAD', producing 0,: (or 
H,O, or both) as follows: 
Xanthine - H,O - 20, (XO) -j uric acid t 20, + 2H ' 
As hypothesized by McCord (60), the elevated cytosolic 
Ca2 + concentration, which results from ischemia as 
described above, activates a protease capable of con- 
verting XD to XO. Concomitantly, the consumption of 
the residual amounts of ATP results in an elevated 
concentration of AMP, which is further catabolized to 
adenosine, inosine and then hypoxanthine. This hypox- 
anthine and xanthine serve as oxidizable substrates for 
XD or XO. Thus during anoxia a new enzyme activity 
appears along with one of its two required substrates. 
During anoxia, however, almost no oxygen-derived free 
radicals are produced because the remaining substrate 
required for XO activity - 0, -is absent. During reper- 
fusion of the tissue, 0, is suddenly abundant. This 
results in a burst of oxygen-derived free radicals and 
H,O, production. If the tissue is anoxic for even a short 
period, a rapid increase in the amount of XO activity 
occurs. In the liver, XO content doubles after about 30 
min (this is about the same in spleen, lung and kidney) 
(60). In the heart, the same increase requires only 8 min 
of nonperfusion. Skeletal muscle is unique in this 
respect because XD does not convert to XO during 
nonperfusion; this correlates well with the clinically 
observable resistance of skeletal muscle to ischemic 
injury. 
In contradiction to this mechanism of generation of 
oxygen-derived free radicals, Metzger et al. (90) found no 
evidence for a role of XO in hepatic reperfusion injury. 
In a model of reperfusion after a period of warm 
ischemia of the rat liver, they found no effect of 
allopurinol (an inhibitor of xanthine oxidase) and dem- 
onstrated the oxidant stress not to be maximal when the 
available concentration of substrates for XO is highest 
(i.e., a t  the onset of reperfusion). This study, however, 
used a model of warm ischemia in which the initiation of 
oxygen-derived free radicals may be quite dissimilar to 
the cold-ischemia situation. Indeed, Marzi et al. (91) 
observed a rapid accumulation of xanthine and hypo- 
xanthine after simple cold storage of the rat liver, which 
is consistent with the hypothesis that XO generates free 
radicals during reperfusion. 
Another possible source of oxygen-derived free rad- 
icals may be the activation of leukocytes and resident 
macrophages (90, 92). These cells can generate large 
amounts of toxic mediators such as oxygen-derived free 
radicals, leukotrienes and proteases. This activation 
may be induced by surface receptors of endothelial cells, 
exposed by anoxic damage (as has been demonstrated in 
other models) (91, 93). In this case the oxygen-derived 
free radicals are probably released by membrane- 
associated enzymes such as lipoxygenase and cyclooxy- 
genase, which are active in arachidonic acid metabolism 
(85). 
What has not been clarified is why the naturally 
occurring scavenging mechanisms - in particular super- 
oxide dismutase (SOD) - are unable to dismutate the 
oxygen-derived free radicals a t  reperfusion. However, 
because no need exists for these during anoxia, they may 
be chemically altered during this period. Corresponding 
with this assumption, decreased SOD activity has been 
measured during hypoxia (94, 95). The simplest expla- 
nation, however, is that a relative overload of oxygen- 
derived free radicals arises at reperfusion. The relatively 
high oxygen tensions in the situation of inadequately 
functioning mitochondria, damaged during the ischemic 
period, and decreased scavenging mechanisms may 
result in a high free radical load, culminating in further 
membrane damage and cell death (84). 
It appears that oxygen-derived free radicals play a 
major role in the development of reperfusion injury. The 
actual source of the toxic oxygen species, however, is not 
known. On the basis of currently available data it 
may be hypothesized that - at  reperfusion after warm 
ischemia- the main source of oxygen-derived free rad- 
icals is the activation of leukocytes and macrophages to 
injure the sinusoidal lining cells. This is in agreement 
with the assumption that direct injury to the cy- 
toskeleton and the resulting alteration of surface re- 
ceptors are the most important consequences of anoxic 
damage. Reperfusion after cold ischemia probably in- 
duces an overload of oxygen-derived free radicals mainly 
produced by XO. In the latter mechanism, increased 
cytosolic Ca"+ levels during anoxia may play an im- 
portant role. The potential mechanisms of anoxic and 
reperfusion damage are depicted in Figure 3. 
CYTOPROTECTIVE COMPOUNDS IN 
LIVER PRESERVATION 
The term iicytoprotection" stems from the obser- 
vation that prostaglandins could protect epithelial cells 
of hollow gastrointestinal viscera against various ulcero- 
genic agents that would otherwise produce cell damage 
and necrosis (96). This advantageous effect appeared not 
to be limited to the digestive tract (97). To date, the 
concept of hepatocytoprotection represents the bene- 
ficial property of any agent preventing harvest injury. In 
the next section, some of the various drugs (Table 4) are 
described and considerations of the working mechanism 
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F’Ic. 3. Hypothesized mechanism of harvest injury. Warm ischemia (and cold ischemia at  a lower rate) causes depletion of ATP (a). This induces 
damage to the energy-requiring cytoskeleton of the hepatocyte (b) (and to the nonparenchymal cells; not shown). ATP is broken down stepwise, 
leading to an accumulation of hypoxanthine (c). With longer-lasting cold ischemia, Caa ’ accumulates (d). Directly, but also by activation of 
various phospholipases and proteases, this leads to cytoskeleton damage in the hepatocyte (e) (and to the nonparenchymal cells; not shown). 
Simultaneously, this activation of proteases induces a rapid conversion of XD to XO oxidase (0. Consequently, both activated enzyme (XO) and 
its substrate (hypoxanthine) are abundant. At reperfusion, oxygen is supplied in excess, leading to a burst of intracellular oxygen-derived free 
radicals (g), which also adds to the parenchymal damage (h). At reperfusion, polymorphonuclear leukocytes (i) and Kupffer cells are activated 
by tissue antigens of endothelial cells (which have come to expression by the preceding anoxic injury) to produce extracellular oxygen-derived 
free radicals and other toxic mediators Q). This causes escalation of nonparenchymal damage (k). H = hepatocyte; N = nucleus; 
EC = endothelial cell; KC = Kupffer cell; PMN = polymorphonuclear leukocyte; PD = parenchymal damage; NPD = nonparenchymal 
damage; 1 = Ca2+ entry-blockers and MP-re la ted  mechanisms; 2 = direct prevention of oxygen-derived free radical generation; 
3 = scavengers of intracellular oxygen-derived free radicals; and 4 = scavengers of extracellular oxygen-derived free radicals. 
are given, arranged as to the composition of warm and 
cold ischemic and anoxic and reperfusion damage to 
hepatocytes and endothelial cells, as described above and 
illustrated in Figure 3. 
Calcium- and cAMP-related Mechaniems. Agents in 
this category act by reducing the intracellular Ca2+ 
accumulation induced by anoxia as delineated above. As 
already pointed out, the interrelationship of Ca2+ and 
CAMP is not understood. However, CAMP has been 
reported to produce an immediate and transient efflux of 
Ca2+ in perfused livers of rats (98). Hypothetically, this 
is caused by the inhibition of the generation of the 
Ca2 + -calmodulin complex (Fig. 4). This results in free 
calmodulin, which facilitates the extrusion of the simul- 
taneously released Ca2 + , On the other hand, CAMP may 
also directly promote Ca2+ efflux. Calmodulin and 
CAMP are believed to act by the Ca2+-specific ATPase 
(99). Therefore, drugs believed to invoke CAMP pro- 
duction are included in this category also. 
Ca2+ entry blockers such as verapamil bind to 
membrane structures responsible for the “slow chan- 
nels.” The presumed efficacy of these drugs, however, 
may be questioned because no potential gated “slow 
Ca2 + channels” have been described in nonexcitable 
tissues (50). Still, diltiazem has been demonstrated to 
have a protective effect in liver ischemia and reperfusion 
in pigs (loo), and verapamil has been shown to be useful 
in combination with prostaglandin I, after 24-hr liver 
preservation (101) and to increase the tolerance of the 
rat liver to ischemia (102). This seeming contradiction 
may be explained by the fact that calcium blockers not 
only change plasma membrane Ca2 + transport but may 
also protect cells by inhibiting Ca2+ mobilization from 
intracellular sources (103). 
Isoproterenol has a p,-mimetic effect and activates 
adenylate cyclase, increasing CAMP (104). Lambotte 
et al. (105) have demonstrated the protective effect 
of isoproterenol in orthotopic canine liver transplan- 
tation. 
Chlorpromazine is an antagonist of histamine, 
a-adrenergic and dopamine receptors. It is, however, 
also suggested to act by Ca2+-calmodulin antagonism 
(106), and it has been shown to suppress the activity of 
phospholipases (107) and to stabilize lysosomes (108). 
Nonetheless, the efficacy of chlorpromazine is contro- 
versial (105, 109, 110). 
Dibucaine inhibits phospholipase 4. Theoretically, it 
may therefore prevent injury by inhibiting the Ca2 + - 
related activation of phospholipase 4. Its cytoprotective 
effects are a matter of controversy (111, 112). 
Aprotinin is a naturally occurring inhibitor of prote- 
olytic enzymes; it therefore may possess cytoprotective 
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TABLE 4. Agents used to prevent oxygen-derived free 
radical-induced harvest idum 

















Direct prevention of 0, : formation 
Oxygen-derived free radical scavengers 
effects caused by inhibition of Ca2 +-related activation of 
proteases (1 13). 
Conventionally, the cytoprotective effects of cortico- 
steroids are attributed to their membrane-stabilizing 
properties (see below) (114). However, an enormous 
variety of mechanisms of action are ascribed to these 
drugs, many theoretical. The antiphlogistic effect, for 
which corticosteroids are famous, is probably caused by 
inhibition of the arachidonic acid production required to 
activate the enzymatic pathway of inflammation (pros- 
taglandins and leukotrienes). This is achieved as follows: 
corticosteroids stimulate the synthesis of a protein 
called lipomodulin, which in its turn inhibits the activity 
of phospholipases (note the resemblance with calmod- 
ulin), preventing the initial release of arachidonic acid 
(115). The role of corticosteroids in preventing harvest 
injury remains to be established. 
In the 1930s, three laboratories independently de- 
scribed a uterine smooth muscle-contracting activity 
deriving from semen. It was termed prostaglandin 
because it was assumed to originate in the prostate 
gland. The first two were called prostaglandin E and F, 
with respect to their solvent partitioning into ether and 
phosphate (fosfat in Swedish). A prostaglandin (PG) is a 
20-carbon fatty acid that contains a five-carbon ring. 
Nine groups of PGs have been identified and assigned 
the letter designations A through I, followed by a 
subscript denoting the number of carbon-carbon double 
bonds outside the ring. The latest-discovered PG, PGI,, 
has been shown to possess a variety of interesting 
biological activities, including inhibition of platelet 
aggregation, vasodilatation, stabilization of lysosomal 
membranes and increase of blood flow to the splanchnic 
region (116-118). All these effects, which are also 
attributed to PGE,, may play a role in the hepatocyto- 
protective properties of PGs. Araki and Lefer (1191, 
however, convincingly showed that the stabilization of 
lysosomal membranes by PGI, is probably the most 
prominent mechanism. This stabilization of lysosomal 
membranes, however, is no more than a description of 
what can be demonstrated when cells are protected by 
mechanisms - still to be elucidated - resulting in dimin- 
ished cell death as measured by the reduced appearance 
of lysosomal enzymes. Therefore other theories of the 
mechanism of action of PGs are required. In this respect 
it is proposed that the cytoprotective action of PGs is 
related to the well-established mechanism of platelet 
aggregation inhibition: PGI, and PGE, stimulate 
platelet adenyl cyclase, leading to an increase in platelet 
CAMP (117). As shown above, CAMP may play a key role 
in preventing liver harvest injury in an intricate inter- 
action with Ca'' and calmodulin (120). The fact that 
PGE, has been shown to inhibit adenyl cyclase in fat 
cells demonstrates that PGs may have opposite effects in 
different tissues (121). 
The hepatocytoprotective properties of the PGI, and 
PGE, has been reported by various authors, and their 
efficacy is reproducible in a variety of models (1, 100, 
122-125). Of particular interest in this respect is the 
report of Araki and Lefer (119), who demonstrated 
protection of hypoxia-induced liver damage in an iso- 
lated perfused cat liver model using PGI,. Using PGI, as 
additive to the preservation fluids, a significant im- 
provement of animal and graft survival and graft 
function was obtained after orthotopic liver transplan- 
tation in dogs and pigs with liver grafts stored for 24 and 
48 hr (101, 126, 127). In human liver transplantation, 
PGE, has been shown to significantly improve graft 
function and decrease graft damage (128). In addition, 
PGE, has been useful in treating fulminant hepatic 
failure (129) and in treating primary graft nonfunction 
(130). 
Direct Prevention of 027 Formation. Allopurinol is 
known to be an XO inhibitor because it decreases the 
breakdown of xanthine and hypoxanthine to urate in 
gouty arthritis. Several studies have shown a protective 
effect of allopurinol against ischemia-induced renal 
injury (131). Initially, these beneficial effects were 
thought to be established by preventing the loss of 
purine bases from the anoxic cell. Once degradation of a 
nucleotide has proceeded beyond the xanthine- 
hypoxanthine level to uric acid, there is no way back to 
generate ATP. At present, however, it is generally 
accepted that allopurinol owes its beneficial effect in 
ischemia to prevention of generation of oxygen-derived 
free radicals (132). In addition, it is postulated that 
allopurinol has radical-scavenging properties (1 33). Al- 
lopurinol has been used in liver ischemia with contra- 
dictory results (30, 90, 134). 
Oxygen-derived Free Radical Scavengers. As already 
mentioned, physiologically occurring oxygen-derived 
free radical scavengers are abundant in a variety of 
human and animal tissues; this suggests that this 
enzyme plays a significant, even vital, role in protecting 
the organism against the damage of 0,:. 
In particular, SOD (135) has been studied extensively 
(82). With respect to liver preservation, it has been 
shown experimentally that SOD is effective in dimin- 
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FIG. 4. Schematic diagram depicting the hypothesized role of CAMP and the Ca2 + -calmoddin complex as intracellular second messengers. 
When a hormone binds to its membrane receptor fR), this activates adenylate cyclase fAC). CAMP synthesized by the AC diffuses through the 
cytoplasm and activates the phosphorylation of specific substrate proteins (S), usually enzymes. Phosphorylation activates these enzymes, 
denoted as S - P, which in turn produce the cell-specific effects. The Ca2 + -calmoddin complex has a similar pathway for inducing certain 
effects. Furthermore, CAMP inhibits the formation of the Ca2+ -calmoddin complex and probably facilitates Ca2 + extrusion by Ca2 ’ -ATPase 
in the cell membrane. 
ishing the extent of harvest injury (82, 136). These 
results, however, are still subject of discussion: 
Southard et al. (137) questioned the potential effect of 
oxygen-derived free radical scavengers in liver preser- 
vation in a study in which they measured XO and SOD 
activity of liver and kidney tissue of rats, dogs and 
humans. In the human, the highest concentrations of 
SOD were found in the intestine and liver. Nevertheless, 
no data exist on the activity of endogenous scavenger 
enzymes after long-term cold storage of these organs. It 
is conceivable that these enzymes are chemically altered, 
since there is no or a limited need for these scavenging 
mechanisms during anoxia, because free radical gener- 
ation is very limited in the absence of oxygen (84). 
Others suggest that exogenous SOD is not likely to enter 
cells to detoxify 0 , ~  generated in hepatocytes (138). For 
that reason, the effects of exogenous SOD may be 
confined to prevention of damage caused by extracellu- 
larly generated 0, (leukocytes). 
In addition, various nonphysiological agents have 
been shown to have scavenging properties. Chelators 
block Fez + -related propagation reactions of oxygen- 
derived free radicals, and mannitol and dimethylnitro- 
samine are known hydroxyl radical scavengers. Their 
potential beneficial effects in liver preservation are open 
to speculation. 
Unknown Mechanisms of Action. Because the mech- 
anisms of the previously mentioned agents are mainly 
hypothetical, no more than descriptions of the chemical 
properties are available of the following drugs, without 
an understanding of the relationship with the suggested 
efficacy in preventing harvest injury. 
Coenzyme Q,,  is a quinone derivate (with 10 isoprene 
units) and is a highly mobile carrier of electrons between 
the flavoproteins and the cytochromes (b-cl-c-da3) of 
the electron-transport chain in mitochondria. It may act 
as an antioxidant in the protection of oxygen-derived 
free radical-induced damage (139-141). 
Phenoxybenzamin blocks receptors for histamine (11, 
acetylcholine and serotonin. It has been shown to be 
useful in kidney preservation, but its value in liver 
preservation is a matter of controversy (2, 109, 111). 
Corticosteroids are mentioned again in this category 
to stress the fact that the “lysosomal stabilization” is 
not what can be called a biochemical mechanism of 
action and that the real mechanism of action of 
corticosteroids is still to be elucidated. The latter 
accounts for all other agents with no other interpre- 
tation of their effects than “stabilization of lysosomal 
membranes.” 
U W  SOLUTION 
By reconsidering the components of cold-storage 
solutions for organ preservation, a new solution was 
developed at the University of Wisconsin by a pioneer in 
the field of organ transplantation, Folkert Belzer. In 
1987, Wahlberg et al. (142) reported the first results of 
72-hr preservation of the canine pancreas with the so 
called UW solution. Soon, successful 24- to 48-hr simple 
cold storage of the canine liver was described (6). In 
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TABLE 5. Composition of and rationale for ingredients of better than any obtained to date with any technique of 
UW solution 
Substance Amountll L Rationale 
Basic components 
K ' -1actobionate 100 mmol Barrier 
NaKH,P04 25 mmol Buffer 
&!SO, 5 mmol Membrane stabili- 
Raffinose 30 mmol Oncotic support 
Hydroxyethyl starch 50 gm Colloid 
Allopurinol 1 mmol XO inhibitor 
Glutathione 3 mmol Scavenger 
Adenosine 5 mmol ATP precursor 
Insulin 100 IU 
Penicillin 40 IU 
Dexamethasone 8 mg 
zation 
Additives 
The solution is brought to pH 7.4 at room temperature with NaOH. 
Final osmolality is 320 mOsm/L. 
March 1988, Kalayoglu and co-workers (143) reported 
the first clinical use of this new preservation solution in 
liver transplantation. Tolerance of cold ischemia by the 
human liver appeared to be significantly improved from 
8 hr  or less with Collins' solution to more than 10 hr  
(range = 11 to 20 hr) in nine cases. 
The key to the success of this advance lay in the 
approach of these investigators to organ preservation 
because they recognized the different metabolic aspects 
of the various organs. Because the success of cold storage 
preservation is primarily related to the prevention of 
tissue edema, the selection of an organ-specific was the 
most important aspect (143). 
Besides the reduction of cellular swelling, the fol- 
lowing requirements for the new solution were defined: 
prevention of intracellular acidosis, prevention of ex- 
pansion of the interstitial space during the flush-out 
period, prevention of injury from oxygen-derived free 
radicals and availability of substrates for regenerating 
high-energy phosphate compounds during reperfusion. 
Table 5 shows the composition of the UW solution. The 
solution is based on lactobionate and raffinose as 
impermeants to suppress hypothermia-induced tissue 
swelling, replacing glucose and mannitol in Collins' 
solution and hypertonic citrate, respectively. The latter 
sugars are effective as impermeants in the kidney, but 
the liver shows free permeability to these small carbo- 
hydrates, rendering them unsuitable as impermeants. 
Phosphate is included in the solution as a buffer to  
prevent tissue acidosis, induced by the increased rate of 
anaerobic metabolism in the ischemic cells. Hydroxy- 
ethyl starch is added as a colloid for oncotic support 
during the flush-out period. Allopurinol and reduced 
glutathione are included as free radical scavengers and 
magnesium sulfate is used for its presumed membrane- 
stabilizing properties. Adenosine is added as a precursor 
for ATP resynthesis. 
Obviously some agents are added for theoretical 
reasons only. Although results with UW solution are 
liver Preservation, the composition is somewhat am- 
biguous with respect to the role of oxygen-derived free 
radicals in harvest injury. Adhering to the hypothesis 
that oxygen-derived free radicals are responsible for 
most harvest injuries, it is apparent that adenosine 
could serve as a substrate for XO. In that way it could 
stimulate the formation of free radicals. Belzer and 
Southard (5) do recognize this problem in stating that 
omitting adenosine from the UW solution may be 
necessary when using it in lung or intestine preser- 
vation. The fact that they do include adenosine in the 
liver storage solution is based on earlier studies on the 
XO and SOD activity in the liver and kidney (137). These 
observations suggested that oqgen-derived free radicals 
may be of little significance in human livers and kidneys. 
Still, allopurinol is added as a free radical scavenger. 
Another important consideration in this multifac- 
torial approach is the fact that no attempt was made to 
gain an increase in cellular CAMP, whereas theoretical 
propositions and experimental evidence are accumu- 
lating to show that this could be an important early step 
in the prevention of intracellular Ca2 + accumulation, as 
shown above (120). Therefore, prostaglandins may 
theoretically be a valuable additive to the UW solution. 
It is remarkable how little is known about the exact 
role of the various additives of the UW solution in 
preventing harvest injury. Therefore, in trying to 
define the relevance of the various components of the 
UW solution empirically, the omission of several addi- 
tives has been investigated. Recently Jamieson et al. 
(144) demonstrated that raffinose, lactobionate and 
gluthatione could not be omitted. However, in their 
experiment, after 48 hr  of ice storage rabbit livers were 
reperfused ex uiuo, and organ transplantation was not 
performed to confirm graft viability. Except for the 
finding that colloid improved the rheological properties 
of the UW solution, none of the additives besides the 
basic components improved preservation in kidney 
transplantation (145). 
Another interesting subject is the development of 
variants of the UW solution in which high K' concen- 
tration is replaced by high Na' concentration. This has 
a number of potential advantages, one being the fact that 
solutions containing high K+ levels (UW solution) can 
induce serious endothelial damage. Indeed, the high-K + 
UW version appeared to be equally or slightly more 
effective (146, 147). 
CONCLUSIONS AND FUTURE DIRECTIONS 
With improving technical proficiency and the intro- 
duction of cyclosporine, liver transplantation has 
evolved to a well-established treatment of end-stage 
cirrhosis. Extensive research resulted in a substantial 
advance in the most prominent feature of liver trans- 
plantation at the moment: organ preservation. Because 
the liver is threatened by multiple important hazards at 
organ procurement and during subsequent storage and 
reperfusion, a multifactorial approach was shown to be 
essential in the development of an effective cold storage 
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solution and safely preserving liver grafts over a period 
long enough to perform liver transplantation as an 
elective procedure. 
Many interesting aspects of organ preservation will be 
the subject of further investigation in the future. The 
combination of cold storage - to harvest and to transport 
the donor organ - and subsequent placement on a 
perfusion machine once it arrives in the actual trans- 
plantation center-to enable selection of the most 
suitable recipient - is one of the promising modifi- 
cations. It has already been reported to provide suc- 
cessful 5-day preservation of the canine kidney (148). 
Another major topic in the near future will be 
assessment of graft viability. Nuclear magnetic reso- 
nance imaging (149) and other methods to measure the 
loss of liver nucleotides and energy charge (150-153) and 
biochemical assays of the liver perfusate (67) may 
provide sensitive markers to predict graft viability 
before transplantation. 
Future studies of other mechanisms of harvest injury, 
incorporating the above-mentioned and/or other addi- 
tives to the preservation solution, will be necessary to 
further prolong the safe storage period. This could 
permit donor-recipient tissue-matching and reduce the 
emergency aspects of liver transplantation. 
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